ARK Genomic Revolution ETF Sees Unusually High Options Volume (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKG) was the recipient of some unusual options trading activity on Thursday. Investors bought 14,158 put options on the company. This is an increase of 60% compared to the average volume of 8,868 put options.

Institutional Trading of ARK Genomic Revolution ETF

Institutional investors have recently added to or reduced their stakes in the business. Envestnet Portfolio Solutions Inc. acquired a new stake in shares of ARK Genomic Revolution ETF in the third quarter worth $274,000. BKM Wealth Management LLC acquired a new position in ARK Genomic Revolution ETF during the 4th quarter valued at $78,000. Banque Pictet & Cie SA acquired a new position in ARK Genomic Revolution ETF during the 3rd quarter valued at $264,000. Sweet Financial Partners LLC acquired a new position in ARK Genomic Revolution ETF during the 4th quarter valued at $525,000. Finally, International Assets Investment Management LLC raised its stake in ARK Genomic Revolution ETF by 120.1% during the 4th quarter. International Assets Investment Management LLC now owns 107,617 shares of the company’s stock valued at $3,280,000 after purchasing an additional 58,715 shares during the last quarter.

ARK Genomic Revolution ETF Trading Down 0.1 %

Shares of ARKG opened at $23.55 on Friday. The company’s 50 day moving average is $28.95 and its 200 day moving average is $28.46.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.